Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Torsten Haferlach

Showing results (411-420 of 598) with videos related to

Pageof 60
Sort By:
Nature Communications|September 29, 2021
The leukemic oncogene EVI1 hijacks a MYC super-enhancer by CTCF-facilitated loopsSophie Ottema, Roger Mulet-Lazaro, Claudia Erpelinck-Verschueren, et al.
Leukemia|August 26, 2023
Genomics of deletion 7 and 7q in myeloid neoplasm: from pathogenic culprits to potential synthetic lethal therapeutic targetsMinako Mori, Yasuo Kubota, Arda Durmaz, et al.
Leukemia|May 18, 2021
SF3B1 as therapeutic target in FLT3/ITD positive acute myeloid leukemiaInge van der Werf, Anna Wojtuszkiewicz, Huilan Yao, et al.
Leukemia|July 17, 2021
Author Correction: SF3B1 as therapeutic target in FLT3/ITD positive acute myeloid leukemiaInge van der Werf, Anna Wojtuszkiewicz, Huilan Yao, et al.
Hematology (Amsterdam, Netherlands)|November 10, 2005
Treatment of AML in biological subgroupsThomas Buechner, Wolfgang E Berdel, Claudia Schoch, et al.
Biorxiv : the Preprint Server for Biology|January 18, 2024
Single-cell transcriptional mapping reveals genetic and non-genetic determinants of aberrant differentiation in AMLAndy G X Zeng, Ilaria Iacobucci, Sayyam Shah, et al.
Blood Cancer Discovery|April 28, 2025
Single-cell Transcriptional Atlas of Human Hematopoiesis Reveals Genetic and Hierarchy-Based Determinants of Aberrant AML DifferentiationAndy G X Zeng, Ilaria Iacobucci, Sayyam Shah, et al.
Annals of Hematology|October 16, 2023
Detection of a rare JAK2<sup>exon13InDel</sup>-mutation in chronic eosinophilic leukemia with bilateral cerebral infarctions and Löffler endocarditisSven Eisenach, Jan Zinke, Dirk Brämer, et al.
Therapeutic Advances in Hematology|June 23, 2025
Integrated Immune Landscape Analysis of RNA Splicing Factor-Mutant AML and Higher risk MDS Treated with Azacitidine ± DurvalumabJan Philipp Bewersdorf, Vanessa Hasle, Rory M Shallis, et al.
Nature Communications|January 15, 2015
Aberrant splicing of U12-type introns is the hallmark of ZRSR2 mutant myelodysplastic syndromeVikas Madan, Deepika Kanojia, Jia Li, et al.
Pageof 60

Showing results (411-420 of 598) with videos related to

Sort By:
Pageof 60
Nature Communications|September 29, 2021
The leukemic oncogene EVI1 hijacks a MYC super-enhancer by CTCF-facilitated loopsSophie Ottema, Roger Mulet-Lazaro, Claudia Erpelinck-Verschueren, et al.
Leukemia|August 26, 2023
Genomics of deletion 7 and 7q in myeloid neoplasm: from pathogenic culprits to potential synthetic lethal therapeutic targetsMinako Mori, Yasuo Kubota, Arda Durmaz, et al.
Leukemia|May 18, 2021
SF3B1 as therapeutic target in FLT3/ITD positive acute myeloid leukemiaInge van der Werf, Anna Wojtuszkiewicz, Huilan Yao, et al.
Leukemia|July 17, 2021
Author Correction: SF3B1 as therapeutic target in FLT3/ITD positive acute myeloid leukemiaInge van der Werf, Anna Wojtuszkiewicz, Huilan Yao, et al.
Hematology (Amsterdam, Netherlands)|November 10, 2005
Treatment of AML in biological subgroupsThomas Buechner, Wolfgang E Berdel, Claudia Schoch, et al.
Biorxiv : the Preprint Server for Biology|January 18, 2024
Single-cell transcriptional mapping reveals genetic and non-genetic determinants of aberrant differentiation in AMLAndy G X Zeng, Ilaria Iacobucci, Sayyam Shah, et al.
Blood Cancer Discovery|April 28, 2025
Single-cell Transcriptional Atlas of Human Hematopoiesis Reveals Genetic and Hierarchy-Based Determinants of Aberrant AML DifferentiationAndy G X Zeng, Ilaria Iacobucci, Sayyam Shah, et al.
Annals of Hematology|October 16, 2023
Detection of a rare JAK2<sup>exon13InDel</sup>-mutation in chronic eosinophilic leukemia with bilateral cerebral infarctions and Löffler endocarditisSven Eisenach, Jan Zinke, Dirk Brämer, et al.
Therapeutic Advances in Hematology|June 23, 2025
Integrated Immune Landscape Analysis of RNA Splicing Factor-Mutant AML and Higher risk MDS Treated with Azacitidine ± DurvalumabJan Philipp Bewersdorf, Vanessa Hasle, Rory M Shallis, et al.
Nature Communications|January 15, 2015
Aberrant splicing of U12-type introns is the hallmark of ZRSR2 mutant myelodysplastic syndromeVikas Madan, Deepika Kanojia, Jia Li, et al.
Pageof 60